Images
In its “Preguntas Big Van” section, the newspaper La Vanguardia has interviewed IRB Barcelona researcher Meritxell Teixidó about her project, which seeks to develop “shuttles” that transport drugs into the brain. In this regard, 98% of drugs that start to be developed to treat diseases of the central nervous system are abandoned because they cannot cross the barrier that protects the brain. Inspired on bee and scorpion venom, Teixidó has identified several families of peptides capable of crossing this barrier. The research has been possible thanks to the funding of a CaixaImpulse project from the ”la Caixa” Foundation and a project awarded through the La Fundació La Marató de TV3.
Link to La Vanguardia
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
